ARTICLE | Distillery Therapeutics
Neurology
January 18, 2017 7:06 PM UTC
In vitro and rat studies suggest agonizing the GRIN2A signaling pathway could help treat age-related cognitive dysfunction. In brain slices from a rat model of the disease, a tool compound that agoniz...
BCIQ Company Profiles